The potential of desipramine to reverse chloroquine resistance of Plasmodium falciparum is reduced by its binding to plasma protein
- 1 May 1993
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 87 (3) , 303
- https://doi.org/10.1016/0035-9203(93)90137-f
Abstract
Matthew K. Boulter, Patrick G. Bray, Robert E. Howells, Stephen A. Ward; The potential of desipramine to reverse chloroquine resistance of Plasmodium falciparuKeywords
This publication has 9 references indexed in Scilit:
- Lack of effect of desipramine on the response to chloroquine of patients with chloroquine-resistant falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992
- Effect of Plasmodium falciparum malaria infection on the plasma concentration of alpha 1‐acid glycoprotein and the binding of quinine in Malawian children.British Journal of Clinical Pharmacology, 1991
- Desipramine reversal of chloroquine resistance in wild isolates of Plasmodium falciparumThe Lancet, 1990
- DESIPRAMINE AND CYPROHEPTADINE FOR REVERSAL OF CHLOROQUINE RESISTANCE IN PLASMODIUM FALCIPARUMThe Lancet, 1989
- ANTIHISTAMINIC DRUGS THAT REVERSE CHLOROQUINE RESISTANCE IN PLASMODIUM FALCIPARUMThe Lancet, 1989
- Assessment of the contribution of α1-acid glycoprotein to the serum binding of basic drugs using serum treated with sulphosalicylic acid and DEAE-celluloseJournal of Pharmacy and Pharmacology, 1985
- Uptake and/or binding of tricyclic antidepressants in human red cellsLife Sciences, 1985
- Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution techniqueAntimicrobial Agents and Chemotherapy, 1979
- A Pharmacokinetic Approach to the Treatment of DepressionInternational Pharmacopsychiatry, 1971